Table 3.
Caudal | Center | Rostral | |
---|---|---|---|
RVLM | |||
R687 | −12.28 | −11.90 | −11.78 |
R696 | −12.57 | −12.11 | −11.88 |
R698 | −12.66 | −12.43 | −12.12 |
R700 | −12.84 | −12.66 | −12.36 |
R701A | −12.84 | −12.36 | −12.12 |
CVLM | |||
R688 | −13.66 | −13.41 | −13.16 |
R690 | −13.68 | −13.43 | −12.93 |
R695 | −13.56 | −13.22 | −12.30 |
R697 | −13.44 | −13.20 | −12.96 |
R702 | −13.68 | −12.96 | −12.80 |
Bregma levels of the tracer injection site (Center) and the rostral and caudal extent of the tracer diffusion in RVLM or CVLM of all rats used for the double label immunofluorescence studies. Based on the most conservative estimates, RVLM extends from Bregma −11.8 to −12.8 and CVLM extends from Bregma −12.8 to −13.6.